Clinical Trial Update: An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease [Phase 3]

View source ↗

Summary

An open-label extension in Phase 3 evaluated the long-term safety of rotigotine in early-stage Parkinson's disease. The trial is completed and results have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Rotigotine (Neupro) (rotigotine)

Snippet

Sponsor: UCB Pharma | Conditions: Early Stage Parkinson's Disease | Phase 3 | Status: COMPLETED | Results posted: 2010-01-18